Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Humanin

HN, S14G-Humanin

Quick Stats
Studies 491
Trials 100
Score 2
2020 pubmed

Humanin selectively prevents the activation of pro-apoptotic protein BID by sequestering it into fibers.

Morris. Daniel L DL; Johnson. Sabrina S; Bleck. Christopher K E CKE; Lee. Duck-Yeon DY; Tjandra. Nico N

Key Findings

  • Humanin binds to BID and forms mixed fibers that trap BID away from mitochondria
  • Fiber formation blocks BID’s ability to activate apoptosis (cell death)
  • BCL‑xL, an anti‑apoptotic protein, does not form fibers with humanin, indicating selectivity

Practical Outcomes

  • Humanin may have cell‑protective properties that could be useful for longevity or stress resistance, but the research is purely molecular and done in test‑tube conditions. No dosage, delivery method, or safety data for humans are provided, so biohackers should view this as early‑stage evidence rather than a ready‑to‑use protocol.

Summary

The study shows that the tiny protein humanin can stick to a cell‑death protein called BID and pull it into rope‑like fibers, which keeps BID from triggering the cell’s self‑destruct program. This effect is specific – it doesn’t happen with the protective protein BCL‑xL – and is stronger at higher temperatures, pH, or with detergent.

Abstract

Members of the B-cell lymphoma (BCL-2) protein family regulate mitochondrial outer membrane permeabilization (MOMP), a phenomenon in which mitochondria become porous and release death-propagating complexes during the early stages of apoptosis. Pro-apoptotic BCL-2 proteins oligomerize at the mitochondrial outer membrane during MOMP, inducing pore formation. Of current interest are endogenous factors that can inhibit pro-apoptotic BCL-2 mitochondrial outer membrane translocation and oligomerization. A mitochondrial-derived peptide, Humanin (HN), was reported being expressed from an alternate ORF in the mitochondrial genome and inhibiting apoptosis through interactions with the pro-apoptotic BCL-2 proteins. Specifically, it is known to complex with BAX and BID. We recently reported the fibrillation of HN and BAX into &#x3b2;-sheets. Here, we detail the fibrillation between HN and BID. These fibers were characterized using several spectroscopic techniques, protease fragmentation with mass analysis, and EM. Enhanced fibrillation rates were detected with rising temperatures or pH values and the presence of a detergent. BID fibers are similar to those produced using BAX; however, the structures differ in final conformations of the BCL-2 proteins. BID fibers display both types of secondary structure in the fiber, whereas BAX was converted entirely to &#x3b2;-sheets. The data show that two distinct segments of BID are incorporated into the fiber structure, whereas other portions of BID remain solvent-exposed and retain helical structure. Similar analyses show that anti-apoptotic BCL-x<sub>L</sub> does not form fibers with humanin. These results support a general mechanism of sequestration of pro-apoptotic BCL-2 proteins into fibers by HN to inhibit MOMP.

Study Information

Provider

pubmed

Year

2020

Date

2020-10-26T00:00:00.000Z

DOI

10.1074/jbc.ra120.013023